|
|
| (303 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| '''Kidney tumours''' - includes '''malignant kidney tumours''' and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. | | [[Image:Renal oncocytoma.jpg|thumb|250px|A kidney tumour ([[renal oncocytoma]]). (WC/Emmanuelm)]] |
| | '''[[Kidney]] tumours''' - includes '''malignant kidney tumours''' ('''kidney cancer''') and '''benign kidney tumours'''. Medical renal diseases are dealt with in the [[medical renal diseases]] article. |
| | |
| | Pediatric kidney tumours are dealt with in the ''[[pediatric kidney tumours]]'' article. |
|
| |
|
| =Renal specimens= | | =Renal specimens= |
| *Renal biopsy - usually for renal onocytoma vs. renal cell carcinoma (RCC) ''or'' medical diseases - see ''[[medical kidney]]''. | | *[[Renal biopsy]] - usually for [[renal oncocytoma]] vs. renal cell carcinoma (RCC) ''or'' medical diseases - see ''[[medical kidney]]''. |
| *Partial nephrectomy. | | *[[Partial nephrectomy]]. |
| *Nephrectomy. | | *[[Nephrectomy]]. |
| *Nephroureterectomy (includes ureter) - done for [[urothelial cell carcinoma]] (UCC) of the renal pelvis and ureteric UCC. | | *[[Nephroureterectomy]] (includes [[ureter]]) - done for [[urothelial cell carcinoma]] (UCC) of the renal pelvis and ureteric UCC. |
| *Radical nephrectomy (includes the [[adrenal gland]]). | | *[[Radical nephrectomy]] - includes Gerota's fascia. |
| | **May include the [[adrenal gland]].<ref name=Ref_WMSP|288>{{Ref WMSP|288}}</ref> |
|
| |
|
| In excisions done for tumours, a comment should be made about kidney distant from the tumour. People with less renal mass, i.e. less kidney, are predisposed to focal segmental glomerulosclerosis (FSGS).<ref>NEED REF.</ref> | | In excisions done for tumours, a comment should be made about kidney distant from the tumour. People with less renal mass, i.e. less kidney, are predisposed to focal segmental glomerulosclerosis (FSGS). |
|
| |
|
| ==Anatomy== | | ==Anatomy== |
| The anatomy is important for properly staging renal neoplasms.
| |
|
| |
| Layers (superficial to deep): | | Layers (superficial to deep): |
| #Renal fascia (Gerota's fascia). | | #Renal fascia (Gerota's fascia). |
| Line 18: |
Line 20: |
| #Renal capsule. | | #Renal capsule. |
| #Renal parenchyma (cortex). | | #Renal parenchyma (cortex). |
| | |
| | ===Sign out=== |
| | ====Missed renal biopsy==== |
| | {{Main|Missed renal biopsy}} |
|
| |
|
| =Tabular comparison (selected tumours)= | | =Tabular comparison (selected tumours)= |
|
| |
|
| Selected common tumours of the kidney:<ref>{{Ref GUP|281-304}}</ref><ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> | | Selected common tumours of the kidney:<ref name=Ref_GUP281>{{Ref GUP|281-304}}</ref><ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> |
| {| class="wikitable" | | {| class="wikitable" |
| | | | | |
| Line 72: |
Line 78: |
| |- | | |- |
| |IHC | | |IHC |
| | CK7-, EMA+ | | | [[CK7]]-, EMA+ |
| | AMACR+, EMA+, CK7+ | | | AMACR+, EMA+, CK7+ |
| | AMACR+, E-cadherin+, CK7- | | | AMACR+, E-cadherin+, CK7- |
| Line 96: |
Line 102: |
| |- | | |- |
| |Image(s) | | |Image(s) |
| | [http://commons.wikimedia.org/wiki/File:Renal_clear_cell_ca_%281%29_Nephrectomy.jpg CCRCC (WC)] | | | [[Image:Renal_clear_cell_ca_%281%29_Nephrectomy.jpg|thumb|150px| CCRCC (WC)]] |
| | [http://commons.wikimedia.org/wiki/File:Papillary_renal_cell_carcinoma_intermed_mag.jpg PaRCC - intermed. (WC)], [http://commons.wikimedia.org/wiki/File:Papillary_renal_cell_carcinoma_very_high_mag.jpg PaRCC - high (WC)] | | | [[Image:Papillary_renal_cell_carcinoma_intermed_mag.jpg|thumb|150px| PaRCC - intermed. (WC)]], [[Image:Papillary_renal_cell_carcinoma_very_high_mag.jpg | thumb|150px| PaRCC - high (WC)]] |
| | | | | |
| | | | | |
| | [http://commons.wikimedia.org/wiki/File:Oncocytic_chromophobe_rcc_high_mag.jpg ChRCC (WC)] | | | [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg|thumb|150px| ChRCC (WC)]] |
| | [http://commons.wikimedia.org/wiki/File:Renal_oncocytoma2.jpg Oncocytoma (WC)] | | | [[Image:Renal_oncocytoma2.jpg|thumb|150px| Oncocytoma (WC)]] |
| |} | | |} |
| Notes: | | Notes: |
| Line 107: |
Line 113: |
|
| |
|
| ===Tabular comparison of oncocytoma and chromophobe RCC=== | | ===Tabular comparison of oncocytoma and chromophobe RCC=== |
| Histomorphologic features useful to distinguish chromophobe RCC (eosinophilic variant) and oncocytoma:<ref name=pmid9844591>{{Cite journal | last1 = Tickoo | first1 = SK. | last2 = Amin | first2 = MB. | title = Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. | journal = Am J Clin Pathol | volume = 110 | issue = 6 | pages = 782-7 | month = Dec | year = 1998 | doi = | PMID = 9844591 }} | | Histomorphologic features useful to distinguish chromophobe RCC (eosinophilic variant) and oncocytoma:<ref name=pmid9844591>{{Cite journal | last1 = Tickoo | first1 = SK. | last2 = Amin | first2 = MB. | title = Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. | journal = Am J Clin Pathol | volume = 110 | issue = 6 | pages = 782-7 | month = Dec | year = 1998 | doi = | PMID = 9844591 }}</ref> |
| </ref> | | {| class="wikitable sortable" |
| {| class="wikitable" | | ! Morphologic feature |
| |
| | ! [[ChRCC]] (eosinophilic<br> variant) |
| | '''ChRCC (eosinophilic<br> variant)'''
| | ! [[Renal oncocytoma]] |
| | '''Renal oncocytoma'''
| |
| |- | | |- |
| | Nuclear morphology | | | Nuclear morphology |
| Line 139: |
Line 144: |
| |- | | |- |
| | Image | | | Image |
| | [http://commons.wikimedia.org/wiki/File:Oncocytic_chromophobe_rcc_high_mag.jpg ChRCC (WC)] | | | [[Image:Oncocytic_chromophobe_rcc_high_mag.jpg |thumb|150px|ChRCC (WC/Nephron)]] |
| | [http://commons.wikimedia.org/wiki/File:Renal_oncocytoma2.jpg Oncocytoma (WC)] | | | [[Image:Renal_oncocytoma2.jpg |thumb|150px|Oncocytoma (WC/Nephron)]] |
| |} | | |} |
| | |
| | ===Common DDx=== |
| | ====Spindle cell tumours==== |
| | Malignant spindle cell tumours of the kidney: |
| | *[[Renal cell carcinoma with sarcomatoid differentiation]]. |
| | *[[Renal mucinous tubular and spindle cell carcinoma]]. |
| | *[[Wilms tumour]]. |
| | *[[Renal cell carcinoma, unclassified]]. |
| | |
| | Benign spindle cell tumours of the kidney: |
| | *[[Angiomyolipoma]]. |
| | *[[Cystic nephroma]]. |
| | |
| | ====Renal tumours with eosinophilic cytoplasm==== |
| | {{Main|Renal tumours with eosinophilic cytoplasm}} |
| | |
| | =WHO classification of renal neoplasia= |
| | *Based on 2004 iteration - as per WMSP, slightly modified.<ref>{{Ref WMSP|291}}</ref> Online, the classification can [http://www.urosource.com/fileadmin/user_upload/european_urology/PIIS0302283805008316.pdf found here]. |
| | ===Renal cell tumours=== |
| | Common: |
| | *[[Clear cell renal cell carcinoma]]. |
| | *[[Papillary renal cell carcinoma]]. |
| | *[[Renal papillary adenoma|Papillary adenoma]]. |
| | *[[Chromophobe renal cell carcinoma]]. |
| | *[[Renal oncocytoma|Oncocytoma]]. |
| | |
| | Less common: |
| | *[[Multilocular clear cell renal cell carcinoma]]. |
| | *[[Carcinoma of the collecting ducts of Bellini]]. |
| | *[[Renal cell carcinoma, unclassified]]. |
| | *[[Renal medullary carcinoma]]. |
| | *[[Renal tumour with Xp11.2 translocation|Xp11 translocation carcinoma]]. |
| | *[[Mucinous tubular and spindle cell carcinoma]]. |
| | *Carcinoma associated with neuroblastoma. |
| | |
| | ===Metanephric tumours=== |
| | *[[Metanephric adenoma]]. |
| | *[[Metanephric stromal tumour]]. |
| | *[[Metanephric adenofibroma]]. |
| | |
| | ===Nephroblastic tumours=== |
| | *Nephrogenic rests. |
| | *[[Nephroblastoma]]. |
| | |
| | ===Mesenchymal tumours=== |
| | Childhood: |
| | *[[Clear cell sarcoma of the kidney]]. |
| | *[[Rhabdoid tumour]]. |
| | *[[Mesoblastic nephroma|Congenital mesoblastic nephroma]]. |
| | |
| | Adults: |
| | *Unique to kidney: |
| | **[[Juxtaglomerular cell tumour]]. |
| | **[[Renomedullary interstitial cell tumour]]. |
| | Other: |
| | *[[Angiomyolipoma]]. |
| | *[[Epithelioid angiomyolipoma]]. |
| | *[[Leiomyosarcoma]]. |
| | *[[Angiosarcoma]]. |
| | *[[Pleomorphic undifferentiated sarcoma]]. |
| | *[[Hemangiopericytoma]]. |
| | *[[Solitary fibrous tumour]]. |
| | *[[Osteosarcoma]]. |
| | *[[Schwannoma]]. |
| | |
| | ===Mixed mesenchymal and epithelial tumours=== |
| | *[[Cystic nephroma]]. |
| | *[[Mixed epithelial and stromal tumour]]. |
| | *[[Synovial sarcoma]]. |
| | |
| | ===Others=== |
| | *[[Neuroendocrine tumours]]. |
| | *Hematologic tumours. |
| | *[[Germ cell tumour]]s. |
| | *[[Metastases]]. |
| | |
| | ==Vancouver modification of WHO classification== |
| | In 2012/2013, several additions were made:<ref name=pmid24025519>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | last3 = Eble | first3 = JN. | last4 = Egevad | first4 = L. | last5 = Epstein | first5 = JI. | last6 = Grignon | first6 = D. | last7 = Hes | first7 = O. | last8 = Moch | first8 = H. | last9 = Montironi | first9 = R. | title = The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. | journal = Am J Surg Pathol | volume = 37 | issue = 10 | pages = 1469-89 | month = Oct | year = 2013 | doi = 10.1097/PAS.0b013e318299f2d1 | PMID = 24025519 }}</ref> |
| | *[[Tubulocystic renal cell carcinoma]]. |
| | *[[Acquired cystic disease associated renal cell carcinoma]]. |
| | *[[Clear cell papillary renal cell carcinoma]] (clear cell tubulopapillary renal cell carcinoma). |
| | *[[Hereditary leiomyomatosis renal cell carcinoma syndrome associated renal cell carcinoma]]. |
| | *MiT family translocation renal cell carcinoma - includes: |
| | **[[t(6;11) renal cell carcinoma]]. |
| | |
| | "Emerging" entities (as per Vancouver) are: |
| | *[[Thyroid-like follicular renal cell carcinoma]]. |
| | *[[Succinate dehydrogenase-deficient renal cell carcinoma]]. |
| | *[[ALK translocation renal cell carcinoma]]. |
| | |
| | ==Entities proposed after Vancouver== |
| | *[[Eosinophilic, solid and cystic renal cell carcinoma]] - part of 2022 WHO Classification. |
| | *[[Biphasic hyalinizing psammomatous renal cell carcinoma]]. |
| | *[[Papillary renal neoplasm with reverse polarity]]. |
| | *[[Low-grade oncocytic renal tumour]]. |
|
| |
|
| =Renal cell carcinoma= | | =Renal cell carcinoma= |
| Line 149: |
Line 249: |
| *Often abbreviated '''RCC'''. | | *Often abbreviated '''RCC'''. |
| *[[AKA]] ''hypernephroma''.<ref>URL:[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/]. Accessed on: 14 July 2011.</ref> | | *[[AKA]] ''hypernephroma''.<ref>URL:[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001544/]. Accessed on: 14 July 2011.</ref> |
| | | *RCC represents approx. 90% of malignancies in kidneys of adults.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> |
| ===Origin=== | | ===Origin=== |
| *Proximal renal tubule. | | *Proximal renal tubule. |
| Line 161: |
Line 261: |
|
| |
|
| ===Risk factors=== | | ===Risk factors=== |
| *[[Smoking]]. | | *[[Smoking]] - most important.<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> |
| *Some chemicals. | | *Chemical exposures (arsenic, asbestos, cadmium, organic solvents, pesticides, fungal toxins).<ref name=Ref_WMSP289>{{Ref WMSP|289}}</ref> |
| *Hemodialysis. | | *Chronic renal failure. |
| | **[[Acquired cystic renal disease]]. |
| *Male>female (~2:1). | | *Male>female (~2:1). |
| *Hereditary - familial syndromes (see [[Hereditary RCC]]). | | *Hereditary - familial syndromes (see [[Hereditary RCC]]). |
| | *[[Obesity]].<ref name=pmid8770461>{{Cite journal | last1 = Chow | first1 = WH. | last2 = McLaughlin | first2 = JK. | last3 = Mandel | first3 = JS. | last4 = Wacholder | first4 = S. | last5 = Niwa | first5 = S. | last6 = Fraumeni | first6 = JF. | title = Obesity and risk of renal cell cancer. | journal = Cancer Epidemiol Biomarkers Prev | volume = 5 | issue = 1 | pages = 17-21 | month = Jan | year = 1996 | doi = | PMID = 8770461 }}</ref> |
|
| |
|
| ===Subtypes of RCC=== | | ===Subtypes of RCC=== |
| RCC (renal cell carcinoma) comes in different subtypes:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref> | | RCC (renal cell carcinoma) comes in different subtypes:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref> |
| *Clear cell carcinoma (70-80% of RCC) -- abbrev. CCRCC, | | *Clear cell carcinoma (70-80% of RCC) -- abbrev. CCRCC. |
| *Papillary renal cell carcinoma (10-15% of RCC) -- abbrev. PRCC, | | *Papillary renal cell carcinoma (10-15% of RCC) -- abbrev. PRCC. |
| *Chromophobe renal carcinoma (5% of RCC) -- abbrev. ChRCC, | | *Chromophobe renal carcinoma (5% of RCC) -- abbrev. ChRCC. |
| *Collecting duct (Bellini duct) carcinoma (1% of RCC). | | *Collecting duct (Bellini duct) carcinoma (1% of RCC). |
|
| |
|
| Line 177: |
Line 279: |
| *Subtype is an independent predictor of mortality - but adds very little to multivariate models with staging information.<ref name=pmid19076149>{{Cite journal | last1 = Capitanio | first1 = U. | last2 = Cloutier | first2 = V. | last3 = Zini | first3 = L. | last4 = Isbarn | first4 = H. | last5 = Jeldres | first5 = C. | last6 = Shariat | first6 = SF. | last7 = Perrotte | first7 = P. | last8 = Antebi | first8 = E. | last9 = Patard | first9 = JJ. | title = A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. | journal = BJU Int | volume = 103 | issue = 11 | pages = 1496-500 | month = Jun | year = 2009 | doi = 10.1111/j.1464-410X.2008.08259.x | PMID = 19076149 }}</ref> | | *Subtype is an independent predictor of mortality - but adds very little to multivariate models with staging information.<ref name=pmid19076149>{{Cite journal | last1 = Capitanio | first1 = U. | last2 = Cloutier | first2 = V. | last3 = Zini | first3 = L. | last4 = Isbarn | first4 = H. | last5 = Jeldres | first5 = C. | last6 = Shariat | first6 = SF. | last7 = Perrotte | first7 = P. | last8 = Antebi | first8 = E. | last9 = Patard | first9 = JJ. | title = A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. | journal = BJU Int | volume = 103 | issue = 11 | pages = 1496-500 | month = Jun | year = 2009 | doi = 10.1111/j.1464-410X.2008.08259.x | PMID = 19076149 }}</ref> |
| *CCRCC tends to be worse than ChRCC and PRCC, probably due to higher incidence of mets.<ref name=pmid17886093>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Bethwaite | first2 = PB. | last3 = Nacey | first3 = JN. | title = Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. | journal = Pathology | volume = 39 | issue = 5 | pages = 459-65 | month = Oct | year = 2007 | doi = 10.1080/00313020701570061 | PMID = 17886093 }}</ref> | | *CCRCC tends to be worse than ChRCC and PRCC, probably due to higher incidence of mets.<ref name=pmid17886093>{{Cite journal | last1 = Delahunt | first1 = B. | last2 = Bethwaite | first2 = PB. | last3 = Nacey | first3 = JN. | title = Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. | journal = Pathology | volume = 39 | issue = 5 | pages = 459-65 | month = Oct | year = 2007 | doi = 10.1080/00313020701570061 | PMID = 17886093 }}</ref> |
| | *The exam answer (worst to best): clear cell RCC, papillary RCC, chromophobe RCC. |
| | |
| ===IHC - is it RCC?=== | | ===IHC - is it RCC?=== |
| *RCC Ma (+), CD10 (+) -- specific for RCC<ref>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> | | *RCC Ma (+), CD10 (+) -- specific for RCC<ref>{{cite journal |author=Zhou M, Roma A, Magi-Galluzzi C |title=The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms |journal=Clin. Lab. Med. |volume=25 |issue=2 |pages=247?7 |year=2005 |month=June |pmid=15848735 |doi=10.1016/j.cll.2005.01.004 |url=}}</ref> |
| Line 185: |
Line 289: |
| *Papillary RCC type 1 vs. papillary RCC type 2: | | *Papillary RCC type 1 vs. papillary RCC type 2: |
| ** E-cadherin +ve in PRCC type 2.<ref name=pmid14657952>{{cite journal |author=Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R |title=Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |journal=Mod. Pathol. |volume=17 |issue=2 |pages=180? |year=2004 |month=February |pmid=14657952 |doi=10.1038/modpathol.3800032 |url=}}</ref> | | ** E-cadherin +ve in PRCC type 2.<ref name=pmid14657952>{{cite journal |author=Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R |title=Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases |journal=Mod. Pathol. |volume=17 |issue=2 |pages=180? |year=2004 |month=February |pmid=14657952 |doi=10.1038/modpathol.3800032 |url=}}</ref> |
| **EMA (MUC1) +ve in PRCC type 1.<ref name=pmid14657952/> | | **[[EMA]] (MUC1) +ve in PRCC type 1.<ref name=pmid14657952/> |
|
| |
|
| *ChRCC vs. oncocytoma (ONC): | | *ChRCC vs. oncocytoma (ONC): |
| Line 207: |
Line 311: |
| *E-cadherin ''not'' useful for differentiating ChRCC and ONC.<ref name=pmid12613443>{{cite journal |author=Kim MK, Kim S |title=Immunohistochemical profile of common epithelial neoplasms arising in the kidney |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=4 |pages=332–8 |year=2002 |month=December |pmid=12613443 |doi= |url=}}</ref> | | *E-cadherin ''not'' useful for differentiating ChRCC and ONC.<ref name=pmid12613443>{{cite journal |author=Kim MK, Kim S |title=Immunohistochemical profile of common epithelial neoplasms arising in the kidney |journal=Appl. Immunohistochem. Mol. Morphol. |volume=10 |issue=4 |pages=332–8 |year=2002 |month=December |pmid=12613443 |doi= |url=}}</ref> |
|
| |
|
| ==Hereditary RCC== | | ===RCC vs. Urothelial cell carcinoma=== |
| The classics - which are ''all'' autosomal dominant:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref>
| |
| # [[Von Hippel-Lindau syndrome]] (clear cell tumours).
| |
| # Hereditary clear cell carcinoma (VHL gene).
| |
| # Hereditary papillary carcinoma (MET proto-oncogene mutation).
| |
| | |
| Others:
| |
| * Hereditary papillary carcinoma (TFE3 related translocations).<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/314310 http://www.ncbi.nlm.nih.gov/omim/314310]. Accessed on: 16 June 2010.</ref>
| |
| | |
| Review paper:<br>
| |
| {{Cite journal | last1 = Verine | first1 = J. | last2 = Pluvinage | first2 = A. | last3 = Bousquet | first3 = G. | last4 = Lehmann-Che | first4 = J. | last5 = de Bazelaire | first5 = C. | last6 = Soufir | first6 = N. | last7 = Mongiat-Artus | first7 = P. | title = Hereditary renal cancer syndromes: an update of a systematic review. | journal = Eur Urol | volume = 58 | issue = 5 | pages = 701-10 | month = Nov | year = 2010 | doi = 10.1016/j.eururo.2010.08.031 | PMID = 20817385 }}
| |
| | |
| ==Grading RCC==
| |
| ===General===
| |
| Some subtypes are graded based on the '''Fuhrman system''' which considers:<ref name=Ref_GUP282>{{Ref GUP|282}}</ref>
| |
| *Nuclear pleomorphism (size, shape),
| |
| *Chromatin pattern,
| |
| *Nucleoli prominence.
| |
| | |
| Notes:
| |
| *The system was validated for clear cell RCC.
| |
| *Fuhrman nuclear grade is '''not''' prognostic in ''chromophobe RCC'' and should not be used in that context.<ref name=pmid1949485>{{cite journal |author=Brovkina AF, Val'skii VV |title=[Computer tomography in the diagnosis of intraocular melanomas] |language=Russian |journal=Vestn Oftalmol |volume=107 |issue=4 |pages=39–42 |year=1991 |pmid=1949485 |doi= |url=}}</ref>
| |
| | |
| ===Criteria & grades===
| |
| *Grade 1: no nucleoli, near 'normal' appearance.
| |
| *Grade 2: finely granular chromatin (key feature), no nuclei visible with 10x objective lens.
| |
| *Grade 3: [[nucleoli]] seen easily (key feature).
| |
| *Grade 4: prominent pleomorphism (key feature), hyperchromasia, [[macronucleoli]].
| |
| Note: Most tumours are grade 2 & 3.
| |
| | |
| ===Fuhrman grading in short===
| |
| *1 vs. 2: grade 2 has granular chromatin, grade 2 has nucleoli visible @ 20x objective.<ref>AE. June 2010.</ref>
| |
| *2 vs. 3: grade 3 has nucleoli @ 10x objective.
| |
| *3 vs. 4: grade 4 has pleomorphism/hyperchromasia.
| |
| | |
| ==Clear cell carcinoma==
| |
| ===Gross===
| |
| *Gold/yellow.
| |
| *+/-Haemorrhage (common).
| |
| *+/-Necrosis (common in large tumours).
| |
| | |
| ===Microscopic===
| |
| Features:<ref>{{Ref PBoD|1017-8}}</ref>
| |
| *Clear cells.
| |
| *Solid or [[trabecular]] pattern.
| |
| *Delicate branching vasculature.
| |
| | |
| *[[Hyaline bodies]] common.<ref>AFIP Renal Tumours Book.</ref>
| |
| **Not common in papillary RCC.
| |
| | |
| ===IHC===
| |
| *CK7 -ve.
| |
| *CK20 -ve.
| |
| *Hale's colloidal iron -ve.
| |
| **+ve in chromophobe.
| |
| | |
| Note: ''[[Hale's colloidal iron]]'' does not stain iron... it stains hemosiderin.<ref>Latta. 27 January 2009.</ref>
| |
| Clear cell vs. chromophobe:
| |
| *Chromophobe: "translucent" (NOT quite clear), reticulated, +Hale's colloidal iron stain, CK7+ (cell membrane).
| |
| | |
| Clear cell vs. [[adrenocortical carcinoma]]:
| |
| *ACC: EMA- (epithelial membrane antigen), cytokeratin mostly neg., inhibin+ (neg. in RCC).<ref name=Ref_GUP285>{{Ref GUP|285}}</ref>
| |
| | |
| ==Papillary RCC==
| |
| ===General===
| |
| *Often subclassified<ref name=Ref_GUP289>{{Ref GUP|289}}</ref> into ''type 1'' and ''type 2'' -- see below.
| |
| *May be abbreviated ''PRCC''.
| |
| | |
| ===Epidemiology===
| |
| *Associated with ''dialysis associated cystic disease''.<ref>{{Ref PBoD|1017-8}}</ref>
| |
| | |
| ===Microsopy===
| |
| Features:<ref>{{Ref PBoD|1017-8}}</ref>
| |
| *Cuboidal or low columnar cell in papillae.
| |
| *Interstitial foam cells in vascular cores - '''key feature'''.<ref>ALS Feb 9, 2009.</ref>
| |
| **Most sensitive and specific feature of PRCC.<ref>{{cite journal |author=Granter SR, Perez-Atayde AR, Renshaw AA |title=Cytologic analysis of papillary renal cell carcinoma |journal=Cancer |volume=84 |issue=5 |pages=303?8 |year=1998 |month=October |pmid=9801205 |doi= |url=http://dx.doi.org/10.1002/(SICI)1097-0142(19981025)84:5<303::AID-CNCR6>3.0.CO;2-7}}</ref>
| |
| *Highly vascular.
| |
| Mnemonic ''HIP'': '''h'''ighly vascular, '''i'''nterstitial foam cells, '''p'''apillae.
| |
| | |
| Size criterion:
| |
| *Papillary lesions '''''must''''' be >0.5 cm to be called ''carcinoma''; smaller lesions (<=0.5 cm) are called ''papillary adenomas''.<ref name=Ref_GUP288>{{Ref GUP|288}}</ref>
| |
| | |
| Histological subtyping:<ref name=Ref_GUP289>{{Ref GUP|289}}</ref>
| |
| *''Type 1'' - single layer of cells on basement membrane.
| |
| ** usually low grade nuclear features, i.e. low Fuhrman grade.
| |
| *''Type 2'' - pseudostratification of cells.
| |
| ** Usually high grade nuclear features, i.e. high Fuhrman grade.
| |
| | |
| ===IHC===
| |
| Features:<ref name=Ref_GUP289>{{Ref GUP|289}}</ref>
| |
| *AMACR +ve.<ref>ALS Feb 9, 2009.</ref>
| |
| *HMWCK (34betaE12) +ve.
| |
| *Panker (AE1/AE3) +ve.
| |
| *CK7 +ve ~90% of type 1, 20% of type 2.
| |
| | |
| More reading:
| |
| *[http://www.e-immunohistochemistry.info/web/Papillary_renal_cell_carcinoma.htm e-immunohistochemistry.info]
| |
| | |
| ===Clear cell vs. papillary===
| |
| *Papillary: +histiocytes, +intracellular hemosiderin, [[CK7]]+.
| |
| | |
| ==Chromophobe RCC==
| |
| ===General===
| |
| *Sometimes abbreviated ''ChRCC''.
| |
| | |
| There are two subtypes:<ref name=Ref_GUP293>{{Ref GUP|293}}</ref>
| |
| *Classic.
| |
| *Eosinophilic variant.
| |
| | |
| ===Gross===
| |
| *Tan, light-brown.
| |
| *Solitary.
| |
| *Well-circumscribed.
| |
| | |
| ===Microscopic===
| |
| Features - classic type:<ref>{{Ref PBoD|1016-7}}</ref><ref name=Ref_GUP293>{{Ref GUP|293}}</ref>, 3 P's [[mnemonic]]:
| |
| *Pale cytoplasm, with wisps of eosinophilic material; the cells are not completely clear, they have "cobwebs".
| |
| *Perinuclear clearing, i.e. a pale halo surrounds the nucleus - '''key feature'''.
| |
| *Periphery of cell distinct, i.e. cell membrane is easy to discern.
| |
| | |
| Features - eosinophilic variant:<ref name=Ref_GUP293>{{Ref GUP|293}}</ref>
| |
| *Eosinophilic (finely granular) cytoplasm.
| |
| *Perinuclear clearing - '''key feature'''.
| |
| *Periphery of cell distinct.
| |
| *Smaller cells than classic subtype.
| |
| | |
| Notes:
| |
| #May have [[psammoma bodies]].
| |
| #May appear similar to oncotyoma -- particularily the eosinophilic variant.
| |
| #*A comparison based on histomorphology: ''[[Kidney_tumours#Tabular_comparison_of_oncocytoma_and_chromophobe_RCC|Tabular comparison between ChRCC & oncocytoma]]''.
| |
| #**No perinuclear clearing in oncocytoma.
| |
| | |
| Image: [http://commons.wikimedia.org/wiki/File:Oncocytic_chromophobe_rcc_high_mag.jpg Oncocytic chromophobe RCC (WC)].
| |
| | |
| ===IHC===
| |
| *CK7 +ve cell membrane.<ref name=Ref_GUP293>{{Ref GUP|293}}</ref>
| |
| | |
| DDx:
| |
| *May appear similar to oncotyoma -- particularily the eosinophilic variant.
| |
| **IHC may be useful to differentiate (CK7: oncocytoma = cytoplasm +ve, chromophobe = cell membrane +ve).
| |
| *Classic ChRCC may be challenging to differentiate from clear cell RCC.
| |
| **Perinuclear clearing is ''not'' seen in clear cell RCC.
| |
| **ChRCC has wisps in the cytoplasm
| |
| | |
| ==Urothelial cell carcinoma==
| |
| {{main|Urothelium}} | | {{main|Urothelium}} |
| *Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. | | *Clinically/radiologically, it may not be possible to differentiate renal pelvis UCC and RCC if the tumour is large. |
| *Pathologically, this is not very difficult. | | *Pathologically, this is not very difficult. |
| *On gross specimens, it is almost always obvious what one is dealing with: | | *On gross specimens, it is almost always obvious what one is dealing with: |
| **UCC = ''nephroureterectomy''. | | **[[UCC]] = ''[[nephroureterectomy]]''. |
| **RCC = ''partial nephrectomy'', ''nephrectomy'' or ''radical nephrectomy''. | | **[[RCC]] = ''[[partial nephrectomy]]'', ''nephrectomy'' or ''[[radical nephrectomy]]''. |
|
| |
|
| =Benign & mimics= | | ===Renal cell carcinoma with sarcomatoid differentiation=== |
| | *[[AKA]] ''sarcomatoid renal cell carcinoma''. |
| | {{Main|Renal cell carcinoma with sarcomatoid differentiation}} |
|
| |
|
| ==Renal oncocytoma== | | ===Renal cell carcinoma with rhabdoid morphology=== |
| ===General===
| | *[[AKA]] ''renal cell carcinoma with rhabdoid change''. |
| *Can be difficult to distinguish radiologically from RCC (chromophobe subtype). | | {{Main|Renal cell carcinoma with rhabdoid morphology}} |
| ** ... and pathologists occasionally struggle like the radiologists.
| |
| *Benign tumour - the reason it is excised is... one cannot be certain it isn't a RCC.
| |
|
| |
|
| ===Gross=== | | ==Hereditary renal cell carcinoma== |
| *Brown, mahogany brown.
| | {{Main|Hereditary renal cell carcinoma}} |
| *1/3 have a characteristic central scar.<ref name=Ref_GUP302>{{Ref GUP|302}}</ref>
| |
|
| |
|
| Image: [http://en.wikipedia.org/wiki/File:Renal_oncocytoma.jpg Renal oncocytoma with central scar (wikipedia.org)].
| | ==Renal cell carcinoma grading== |
| | {{Main|Renal cell carcinoma grading}} |
|
| |
|
| ===Histology=== | | ==Renal cell carcinoma staging== |
| Features:
| | {{Main|Kidney cancer staging}} |
| *Eosinophilic cytoplasm - slightly granular '''key feature'''.
| |
| *Cells arranged in nests.
| |
| *Nuclei uniform and round.<ref name=Ref_GUP302>{{Ref GUP|302}}</ref>
| |
| **Slightly enlarged nuclei, but '''no significant''' pleomorphism (size variation) - '''important'''.
| |
|
| |
|
| Notes:
| | ===Renal sinus invasion=== |
| *May look like eosinophilic variant of chromophobe RCC -- this is the main DDx.
| | {{Main|Kidney cancer staging}} |
| **A comparison based on histomorphology: ''[[Kidney_tumours#Tabular_comparison_of_oncocytoma_and_chromophobe_RCC|Tabular comparison between ChRCC & oncocytoma]]''.
| |
| ***No perinuclear clearing -- this is seen in ChRCC.
| |
| **IHC may be useful to differentiate (CK7: oncocytoma = cytoplasm +ve, chromophobe = cell membrane +ve).
| |
|
| |
|
| Images:
| | ==Clear cell renal cell carcinoma== |
| *[http://commons.wikimedia.org/wiki/File:Renal_oncocytoma2.jpg High mag. oncocytoma (WC)].
| | {{Main|Clear cell renal cell carcinoma}} |
| *[http://commons.wikimedia.org/wiki/File:Renal_oncocytoma3.jpg Intermed. mag. oncocytoma (WC)].
| |
| *[http://commons.wikimedia.org/wiki/File:Renal_oncocytoma4.jpg Low mag. oncocytoma (WC)].
| |
|
| |
|
| ==Angiomyolipoma== | | ==Multilocular cystic renal cell carcinoma== |
| ===General===
| | {{Main|Multilocular cystic renal cell carcinoma}} |
| *Mostly benign mesenchymal tumour.
| |
| *Presentations: flank pain, hematuria, incidentaloma.<ref name=pmid18805573>{{Cite journal | last1 = Seyam | first1 = RM. | last2 = Bissada | first2 = NK. | last3 = Kattan | first3 = SA. | last4 = Mokhtar | first4 = AA. | last5 = Aslam | first5 = M. | last6 = Fahmy | first6 = WE. | last7 = Mourad | first7 = WA. | last8 = Binmahfouz | first8 = AA. | last9 = Alzahrani | first9 = HM. | title = Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. | journal = Urology | volume = 72 | issue = 5 | pages = 1077-82 | month = Nov | year = 2008 | doi = 10.1016/j.urology.2008.07.049 | PMID = 18805573 }}</ref>
| |
| *AMLs occur may be elsewhere in the body, e.g. liver,<ref name=pmid15498214>{{Cite journal | last1 = Zhang | first1 = SH. | last2 = Cong | first2 = WM. | last3 = Xian | first3 = ZH. | last4 = Wu | first4 = WQ. | last5 = Dong | first5 = H. | last6 = Wu | first6 = MC. | title = [Morphologic variants and immunohistochemical features of hepatic angiomyolipoma.] | journal = Zhonghua Bing Li Xue Za Zhi | volume = 33 | issue = 5 | pages = 437-40 | month = Oct | year = 2004 | doi = | PMID = 15498214 }}
| |
| </ref> but are most common in the kidney.
| |
| *In the [[PEComa]] group of tumours.
| |
|
| |
|
| ===Epidemiology=== | | ==Papillary renal cell carcinoma== |
| *May be associated with [[tuberous sclerosis]] -- 70% have an AML.
| | {{Main|Papillary renal cell carcinoma}} |
| **When compared to sporadic cases:
| |
| ***More often bilateral.
| |
| ***Usually bigger.
| |
|
| |
|
| ===Microscopic=== | | ==Chromophobe renal cell carcinoma== |
| *Muscle.
| | {{Main|Chromophobe renal cell carcinoma}} |
| *Adipose tissue - not always present.<ref name=pmid15584043>{{Cite journal | last1 = Crapanzano | first1 = JP. | title = Fine-needle aspiration of renal angiomyolipoma: cytological findings and diagnostic pitfalls in a series of five cases. | journal = Diagn Cytopathol | volume = 32 | issue = 1 | pages = 53-7 | month = Jan | year = 2005 | doi = 10.1002/dc.20179 | PMID = 15584043 }}</ref>
| |
| *Blood vessels.
| |
|
| |
|
| ====Cytologic features<ref name=pmid15584043>{{Cite journal | last1 = Crapanzano | first1 = JP. | title = Fine-needle aspiration of renal angiomyolipoma: cytological findings and diagnostic pitfalls in a series of five cases. | journal = Diagn Cytopathol | volume = 32 | issue = 1 | pages = 53-7 | month = Jan | year = 2005 | doi = 10.1002/dc.20179 | PMID = 15584043 }}</ref>==== | | ==Clear cell papillary renal cell tumour== |
| *Nuclei - round/ovoid.
| | In the past, it was known as ''clear cell papillary renal cell carcinoma''. |
| *Chromatin - bland.
| | {{Main|Clear cell papillary renal cell tumour}} |
|
| |
|
| ===IHC=== | | ==Unclassified renal cell carcinoma== |
| *Melanocytic markers +ve<ref name=Ref_GUP324>{{Ref GUP|324}}</ref> (e.g. HMB-45 +ve). | | *Abbreviated ''URCC''. |
| *Epithelial markers -ve.<ref name=Ref_GUP324>{{Ref GUP|324}}</ref>
| | {{Main|Unclassified renal cell carcinoma}} |
| *SMA +ve.
| |
| *CD117 +/-.
| |
| Additional paper: <ref name=pmid15584043/>
| |
|
| |
|
| Notes:
| | =Renal translocation carcinomas= |
| *There is a suggestion that an ''epithelioid'' variant is more worisome,<ref name=pmid12352384>{{Cite journal | last1 = Nelson | first1 = CP. | last2 = Sanda | first2 = MG. | title = Contemporary diagnosis and management of renal angiomyolipoma. | journal = J Urol | volume = 168 | issue = 4 Pt 1 | pages = 1315-25 | month = Oct | year = 2002 | doi = 10.1097/01.ju.0000028200.86216.b2 | PMID = 12352384 }}</ref> but this is not the case in all studies.<ref name=pmid18852677>{{Cite journal | last1 = Aydin | first1 = H. | last2 = Magi-Galluzzi | first2 = C. | last3 = Lane | first3 = BR. | last4 = Sercia | first4 = L. | last5 = Lopez | first5 = JI. | last6 = Rini | first6 = BI. | last7 = Zhou | first7 = M. | title = Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. | journal = Am J Surg Pathol | volume = 33 | issue = 2 | pages = 289-97 | month = Feb | year = 2009 | doi = 10.1097/PAS.0b013e31817ed7a6 | PMID = 18852677 }}</ref>
| | ==Renal tumour with Xp11.2 translocation== |
| Ki-67 can be used to help distinguish btw 'em -- epithelioid variant Ki-67 +ve.<ref name=pmid18839327>{{Cite journal | last1 = Ooi | first1 = SM. | last2 = Vivian | first2 = JB. | last3 = Cohen | first3 = RJ. | title = The use of the Ki-67 marker in the pathological diagnosis of the epithelioid variant of renal angiomyolipoma. | journal = Int Urol Nephrol | volume = 41 | issue = 3 | pages = 559-65 | month = | year = 2009 | doi = 10.1007/s11255-008-9473-1 | PMID = 18839327 }}</ref>
| | {{Main|Renal tumour with Xp11.2 translocation}} |
|
| |
|
| ==Xanthogranulomatous pyelonephritis== | | ==Renal tumour with t(6;11) translocation== |
| ===General===
| | *[[AKA]] ''t(6;11) renal cell carcinoma''. |
| *May mimic RCC (esp. radiologically). | | {{main|Renal tumour with t(6;11) translocation}} |
| *Usually lower pole ???
| |
| *Associated with:
| |
| **Diabetes mellitus,
| |
| **History of UTI,<ref name=pmid17987581>{{cite journal |author=Afgan F, Mumtaz S, Ather MH |title=Preoperative diagnosis of xanthogranulomatous pyelonephritis |journal=Urol J |volume=4 |issue=3 |pages=169–73 |year=2007 |pmid=17987581 |doi= |url=}}</ref>
| |
| **Nephrolithiasis,
| |
| **GU obstruction.<ref name=pmid17098659>{{cite journal |author=Al-Ghazo MA, Ghalayini IF, Matalka II, Al-Kaisi NS, Khader YS |title=Xanthogranulomatous pyelonephritis: Analysis of 18 cases |journal=Asian J Surg |volume=29 |issue=4 |pages=257–61 |year=2006 |month=October |pmid=17098659 |doi= |url=}}</ref>
| |
| *Occasionally an indication of nephrectomy.<ref name=pmid17987581/><ref name=pmid17098659/>
| |
| *Most common organism (in the context of nephrectomy specimens) - ''Proteus mirabilis''.<ref name=pmid17098659/>
| |
|
| |
|
| ===Microscopic=== | | =Benign tumours= |
| *Abundant macrophages. | | ==Papillary adenoma of the kidney== |
| *+/-Giant cells.
| | *[[AKA]] ''renal papillary adenoma''. |
| | {{Main|Papillary adenoma of the kidney}} |
|
| |
|
| Image:
| | ==Renal oncocytoma== |
| *[http://commons.wikimedia.org/wiki/File:Xanthogranulomatous_pyelonephritis_cd68.jpg Xanthogranulomatous_pyelonephritis - CD68 IHC (mediawiki.org)].
| | {{Main|Renal oncocytoma}} |
|
| |
|
| ===IHC=== | | ==Angiomyolipoma== |
| *CD68 +ve. | | *Abbreviated ''AML''. |
| *RCC markers (CD10, RCC) all negative.
| | {{Main|Angiomyolipoma}} |
|
| |
|
| DDx:
| | =Mimics= |
| *[[Malakoplakia]].
| | ==Xanthogranulomatous pyelonephritis== |
| **Basophilic inclusions -- inside or outside of macrophages - often size of RBC or larger ([[Michaelis-Gutmann bodies]]). | | *Abbreviated ''XGP''. |
| *RCC - esp. PaRCC (as this has foamy macrophages).
| | {{Main|Xanthogranulomatous pyelonephritis}} |
| *Granulomatous disease.
| |
|
| |
|
| ==Malakoplakia== | | ==Malakoplakia== |
| Line 458: |
Line 388: |
|
| |
|
| =Rare stuffs= | | =Rare stuffs= |
| ==Medullary fibroma== | | ==Juxtaglomerular cell tumour== |
| ===General=== | | *[[AKA]] juxtaglomerular tumour, reninoma.<ref name=pmid18192852>{{Cite journal | last1 = Wong | first1 = L. | last2 = Hsu | first2 = TH. | last3 = Perlroth | first3 = MG. | last4 = Hofmann | first4 = LV. | last5 = Haynes | first5 = CM. | last6 = Katznelson | first6 = L. | title = Reninoma: case report and literature review. | journal = J Hypertens | volume = 26 | issue = 2 | pages = 368-73 | month = Feb | year = 2008 | doi = 10.1097/HJH.0b013e3282f283f3 | PMID = 18192852 }}</ref> |
| *Rare.
| | {{Main|Juxtaglomerular cell tumour}} |
|
| |
|
| ===Epidemiology=== | | ==Renomedullary interstitial cell tumour== |
| *Benign.
| | *[[AKA]] ''medullary fibroma''.<ref name=pmid11054036 >{{Cite journal | last1 = Bircan | first1 = S. | last2 = Orhan | first2 = D. | last3 = Tulunay | first3 = O. | last4 = Safak | first4 = M. | title = Renomedullary interstitial cell tumor. | journal = Urol Int | volume = 65 | issue = 3 | pages = 163-6 | month = | year = 2000 | doi = | PMID = 11054036 }}</ref> |
| | | {{Main|Renomedullary interstitial cell tumour}} |
| ===Gross=== | |
| *Small, white well circumscribed nodule in medulla.
| |
| | |
| ===Microscopic=== | |
| *Spindle cells.
| |
|
| |
|
| ==Metanephric adenoma== | | ==Metanephric adenoma== |
| ===General===
| | *Should '''not''' be confused ''[[mesonephric adenoma]]'', another term for ''nephrogenic adenoma''. |
| *Benign. | | **Memory device: me'''t'''anephric adenoma is a '''t'''umour. |
| *Afflicts adults and occasionally children. | | {{Main|Metanephric adenoma}} |
|
| |
|
| ===Micro=== | | ==Renal epithelial and stromal tumour== |
| Features:<ref name=Ref_WMSP284>{{Ref WMSP|284}}</ref>
| | :Abbreviated ''REST''. |
| *Small uniform cells with:
| | The lumping term for both:<ref name=pmid17414095>{{Cite journal | last1 = Turbiner | first1 = J. | last2 = Amin | first2 = MB. | last3 = Humphrey | first3 = PA. | last4 = Srigley | first4 = JR. | last5 = De Leval | first5 = L. | last6 = Radhakrishnan | first6 = A. | last7 = Oliva | first7 = E. | title = Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. | journal = Am J Surg Pathol | volume = 31 | issue = 4 | pages = 489-500 | month = Apr | year = 2007 | doi = 10.1097/PAS.0b013e31802bdd56 | PMID = 17414095 }}</ref> |
| **Fine chromatin.
| | #[[Mixed epithelial and stromal tumour]]. |
| **No apparent [[nucleolus]].
| | #[[Cystic nephroma]]. |
| **A relatively smooth nuclear membrane.
| |
| *Variable architecture - may be sheets or ductal.
| |
|
| |
|
| DDx:
| | ==Mixed epithelial and stromal tumour== |
| *Epithelioid nephroblastoma (Wilms tumour) - these typically have:
| | *Abbreviated ''MEST''. |
| **Irregular nuclear membrane. | | {{Main|Mixed epithelial and stromal tumour of the kidney}} |
| **Nucleoli.
| |
| **Mitoses (rare in ''metanephric adenoma'').
| |
| *Papillary RCC.<ref name=Ref_WMSP284>{{Ref WMSP|284}}</ref>
| |
|
| |
|
| Images:
| | ==Cystic nephroma== |
| *[http://commons.wikimedia.org/wiki/File:Metanephric_adenoma_high_mag.jpg Metanephric adenoma (WC)].
| | {{Main|Cystic nephroma}} |
| *[http://commons.wikimedia.org/wiki/File:Metanephric_adenoma_high_mag_cropped.jpg Metanephric adenoma - cropped (WC)].
| |
| *[http://www.nature.com/modpathol/journal/v16/n10/fig_tab/3880886f1.html Metanephric adenoma (nature.com)].
| |
| | |
| ==Renal epithelial stromal tumour== | |
| *Abbreviated ''REST''.
| |
| *[[AKA]] ''cystic nephroma'', [[AKA]] ''mixed epithelial stromal tumour (MEST)''<ref>{{Cite journal | last1 = Turbiner | first1 = J. | last2 = Amin | first2 = MB. | last3 = Humphrey | first3 = PA. | last4 = Srigley | first4 = JR. | last5 = De Leval | first5 = L. | last6 = Radhakrishnan | first6 = A. | last7 = Oliva | first7 = E. | title = Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. | journal = Am J Surg Pathol | volume = 31 | issue = 4 | pages = 489-500 | month = Apr | year = 2007 | doi = 10.1097/PAS.0b013e31802bdd56 | PMID = 17414095 }}</ref> - some believe these are separate entities.
| |
| | |
| ===General===
| |
| *Rare - approx. 1.5% of renal neoplasms.<ref name=pmid17454754>{{Cite journal | last1 = Mai | first1 = KT. | last2 = Elkeilani | first2 = A. | last3 = Veinot | first3 = JP. | title = Mixed epithelial and stromal tumour (MEST) of the kidney: report of 14 cases with male and PEComatous variants and proposed histopathogenesis. | journal = Pathology | volume = 39 | issue = 2 | pages = 235-40 | month = Apr | year = 2007 | doi = 10.1080/00313020701230799 | PMID = 17454754 }}</ref>
| |
| *Benign.
| |
| *Prevalence: males > females.
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Cysts lined by simple epithelium with hobnailing - '''key feature'''.
| |
| *Stroma has an ovarian look:
| |
| **''Blue'' (basophilic).
| |
| **''Spindle cells''.
| |
| | |
| Notes:
| |
| *Parenchymal elements (e.g. glomueruli, tubules) are not found in the septa between the cysts.
| |
| | |
| Images:
| |
| *[http://commons.wikimedia.org/wiki/File:Cystic_nephroma_low_mag.jpg Cystic nephroma - low mag. (WC)].
| |
| *[http://commons.wikimedia.org/wiki/File:Cystic_nephroma_intermed_mag.jpg Cystic nephroma - intermed. mag. (WC)].
| |
| | |
| ===IHC===
| |
| Features:<ref name=pmid17454754>PMID 17454754</ref>
| |
| *ER +ve.
| |
| *PR +ve.
| |
| *CD10 +ve.
| |
| | |
| ===DDx===
| |
| *Tubulocystic carcinoma.
| |
|
| |
|
| ==Renal mucinous tubular and spindle cell carcinoma== | | ==Renal mucinous tubular and spindle cell carcinoma== |
| ===General===
| | *[[AKA]] ''renal mucinous tubular spindle cell carcinoma''. |
| *Rare.<ref name=pmid19494850>{{Cite journal | last1 = Srigley | first1 = JR. | last2 = Delahunt | first2 = B. | title = Uncommon and recently described renal carcinomas. | journal = Mod Pathol | volume = 22 Suppl 2 | issue = | pages = S2-S23 | month = Jun | year = 2009 | doi = 10.1038/modpathol.2009.70 | PMID = 19494850 }}</ref> | | *[[AKA]] ''mucinous tubular and spindle cell carcinoma of the kidney''.<ref name=pmid16258504>{{Cite journal | last1 = Brandal | first1 = P. | last2 = Lie | first2 = AK. | last3 = Bassarova | first3 = A. | last4 = Svindland | first4 = A. | last5 = Risberg | first5 = B. | last6 = Danielsen | first6 = H. | last7 = Heim | first7 = S. | title = Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. | journal = Mod Pathol | volume = 19 | issue = 2 | pages = 186-94 | month = Feb | year = 2006 | doi = 10.1038/modpathol.3800499 | PMID = 16258504 }}</ref> |
| *Accepted by WHO in 2004 as a separate entity.<ref name=pmid19805959>{{cite journal |author=Geramizadeh B, Salehipour M, Moradi A |title=Mucinous tubular and spindle cell carcinoma of kidney: a rare case report and review of the literature |journal=Indian J Pathol Microbiol |volume=52 |issue=4 |pages=514–6 |year=2009 |pmid=19805959 |doi=10.4103/0377-4929.56144 |url=}}</ref>
| | {{Main|Renal mucinous tubular and spindle cell carcinoma}} |
| | |
| ===Microscopic===
| |
| Features:<ref name=pmid19066686>{{cite journal |author=Trabelsi A, Stita W, Yacoubi MT, Rammeh S, Hmissa S, Korbi S |title=Renal mucinous tubular and spindle cell carcinoma |journal=Can Urol Assoc J |volume=2 |issue=6 |pages=635–6 |year=2008 |month=December |pmid=19066686 |pmc=2593603 |doi= |url=}}</ref>
| |
| *Mucin - may be scant.
| |
| *Spindle cells.
| |
| | |
| DDx:
| |
| *Sarcomatoid papillary RCC. (???) <ref name=pmid18941398>{{cite journal |author=Dhillon J, Amin MB, Selbs E, Turi GK, Paner GP, Reuter VE |title=Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change |journal=Am. J. Surg. Pathol. |volume=33 |issue=1 |pages=44–9 |year=2009 |month=January |pmid=18941398 |doi=10.1097/PAS.0b013e3181829ed5 |url=}}</ref>
| |
| | |
| ===IHC===
| |
| Features:<ref name=pmid16231179>{{cite journal |author=Ferlicot S, Allory Y, Compérat E, ''et al.'' |title=Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature |journal=Virchows Arch. |volume=447 |issue=6 |pages=978–83 |year=2005 |month=December |pmid=16231179 |doi=10.1007/s00428-005-0036-x |url=}}</ref>
| |
| *CD10 -ve.
| |
| *AE1/AE3 +ve.
| |
| *AMACR +ve.
| |
| *CK7 +ve.
| |
|
| |
|
| ==Collecting duct carcinoma== | | ==Collecting duct carcinoma== |
| ===Epidemiology===
| | {{Main|Collecting duct carcinoma}} |
| *Rare.
| |
| | |
| ===Microscopic===
| |
| Features:<ref name=Ref_GUP295>{{Ref GUP|295}}</ref>
| |
| *Tubular structures with tapered ends.
| |
| *High grade nuclear features (nuclear pleomorphism).
| |
| *High mitotic rate.
| |
| *[[Hobnail pattern]] - cell width smaller at basement membrane than free surface ??? <ref>{{Ref PBoD|1018}}</ref>
| |
|
| |
|
| ==Renal medullary carcinoma== | | ==Renal medullary carcinoma== |
| ===General===
| | {{Main|Renal medullary carcinoma}} |
| *Rare.
| |
| *Associated with sickle cell trait (heterozygotes for the sickle cell allele).<ref name=pmid7528470>{{cite journal |author=Davis CJ, Mostofi FK, Sesterhenn IA |title=Renal medullary carcinoma. The seventh sickle cell nephropathy |journal=Am. J. Surg. Pathol. |volume=19 |issue=1 |pages=1–11 |year=1995 |month=January |pmid=7528470 |doi= |url=}}</ref>
| |
| *Aggressive/poor prognosis.<ref name=pmid17643096>{{Cite journal | last1 = Watanabe | first1 = IC. | last2 = Billis | first2 = A. | last3 = Guimarães | first3 = MS. | last4 = Alvarenga | first4 = M. | last5 = de Matos | first5 = AC. | last6 = Cardinalli | first6 = IA. | last7 = Filippi | first7 = RZ. | last8 = de Castro | first8 = MG. | last9 = Suzigan | first9 = S. | title = Renal medullary carcinoma: report of seven cases from Brazil. | journal = Mod Pathol | volume = 20 | issue = 9 | pages = 914-20 | month = Sep | year = 2007 | doi = 10.1038/modpathol.3800934 | PMID = 17643096 |url = http://www.nature.com/modpathol/journal/v20/n9/full/3800934a.html }}</ref>
| |
|
| |
|
| ===Gross=== | | ==Tubulocystic carcinoma of the kidney== |
| Features:<ref name=pmid17643096>{{cite journal |author=Watanabe IC, Billis A, Guimarães MS, ''et al.'' |title=Renal medullary carcinoma: report of seven cases from Brazil |journal=Mod. Pathol. |volume=20 |issue=9 |pages=914–20 |year=2007 |month=September |pmid=17643096 |doi=10.1038/modpathol.3800934 |url=}}</ref>
| | {{Main|Tubulocystic carcinoma of the kidney}} |
| *Well circumscribed.
| |
| *Medulla.
| |
|
| |
|
| ===Microscopic=== | | ==Acquired cystic disease-associated renal cell carcinoma== |
| Features:<ref name=pmid7528470/><ref name=pmid17643096>{{cite journal |author=Watanabe IC, Billis A, Guimarães MS, ''et al.'' |title=Renal medullary carcinoma: report of seven cases from Brazil |journal=Mod. Pathol. |volume=20 |issue=9 |pages=914–20 |year=2007 |month=September |pmid=17643096 |doi=10.1038/modpathol.3800934 |url=}}</ref>
| | {{Main|Acquired cystic disease-associated renal cell carcinoma}} |
| *Variable architecture:
| |
| **Reticular - classic.
| |
| **[[Adenoid cystic carcinoma]]-like appearance:
| |
| ***Cystic spaces.
| |
| **Yolk sac-like.
| |
| **Tubular.
| |
| *Desmoplastic stroma - prominent.
| |
| *Inflammation:
| |
| **Lymphocytes.
| |
| **Neutrophils - margination in vessels.
| |
|
| |
|
| Kidney disease assoc. with sickle cell disorders:<ref name=pmid7528470/> | | ==Kidney metastasis== |
| *Papillary necrosis.
| | *[[AKA]] ''renal metastasis'', ''metastatic kidney disease''. |
| *Nephrotic syndrome.
| | {{Main|Kidney metastasis}} |
| *Renal infarction.
| |
| *Pyelonephritis.
| |
| | |
| Image:
| |
| *[http://www.nature.com/modpathol/journal/v20/n9/fig_tab/3800934f3.html#figure-title RMC (nature.com)]. | |
|
| |
|
| =Pediatric= | | =Pediatric= |
| ==Wilms tumour==
| | {{Main|Pediatric kidney tumours}} |
| *[[AKA]] nephroblastoma, AKA Wilms' tumour.
| |
| | |
| ===General===
| |
| *Common abdominal [[pediatric pathology|pediatric]] tumour.
| |
| *May be associated with a syndrome:<ref>URL: [http://emedicine.medscape.com/article/989398-overview http://emedicine.medscape.com/article/989398-overview]. Accessed on: 9 March 2011.</ref>
| |
| **WAGR syndrome (Wilms tumour, Aniridia (absence of iris), GU abnormalities, Retardation).<ref>{{OMIM|194072}}</ref>
| |
| **[[Beckwith-Wiedemann syndrome]].<ref>{{OMIM|130650}}</ref>
| |
| **Denys-Drash syndrome.<ref>{{OMIM|194080}}</ref>
| |
| | |
| ===Gross===
| |
| *Lobulated tan mass.
| |
| | |
| Image: [http://library.med.utah.edu/WebPath/EXAM/IMGQUIZ/rnfrm.html Wilms tumour (med.utah.edu)].
| |
|
| |
|
| ===Microscopic===
| | The most common is [[nephroblastoma]] (Wilms tumour). |
| Features - classically three components (blastema, immature stroma, tubules):<ref name=Ref_PCPBoD8_254-5>{{Ref PCPBoD8|254-5}}</ref>
| |
| #Malignant [[Small round blue cell tumours|small round blue cells]] ("blastema"):
| |
| #*Size = ~ 2x RBC diameter.
| |
| #*Nuclear pleomorphism (variation of size, shape and staining).
| |
| #**Irregular nuclear membrane - '''important'''.
| |
| #*Scant/difficult to discern cytoplasm - basophilic (light blue).
| |
| #*Mitoses - common.
| |
| #Stroma ("immature stroma"):
| |
| #*Spindle cells:
| |
| #**Elliptical nuclear membrane.
| |
| #**Abundant loose cytoplasm.
| |
| #Tubular structures ("tubules"):
| |
| #*Usually clustered.
| |
| #*Vaguely resemble a glomerulus.
| |
| #*Usu. have a central (clear/white) space surrounded by a rim of intensely eosinophilic cytoplasm.
| |
| #*Nuclei of tubular structures often elongated and palisaded.
| |
| | |
| Other findings:
| |
| *Commonly seen in association with ''nephrogenic rests''.
| |
| **Cluster of cells small (blue) cells; lack nuclear atypia seen in Wilms tumour.<ref>URL: [http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970416-8 http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970416-8]. Accessed on: 28 March 2011.</ref>
| |
| *+/-Heterologous elements (skeletal muscle, smooth muscle adipose tissue, cartilage).<ref name=Ref_WMSP282>{{Ref WMSP|282}}</ref>
| |
| **Heterologous = doesn't normally belong there.<ref>URL: [http://www.biology-online.org/dictionary/Heterologous http://www.biology-online.org/dictionary/Heterologous]. Accessed on: 1 October 2011.</ref>
| |
| | |
| DDx:
| |
| *Metanephric adenoma.
| |
| *Nephrogenic nests.
| |
| *Other small round cell tumours.
| |
| *[[Synovial sarcoma]] - esp. in adults.
| |
| | |
| Notes:
| |
| *Palisade = fence made of stakes driven into the ground.<ref>URL: [http://www.thefreedictionary.com/palisaded http://www.thefreedictionary.com/palisaded]. Accessed on: 2 February 2011.</ref>
| |
| *Approximately 30-40% Wilms tumour cases have nephrogenic rests.<ref name=pmid8047084>{{cite journal |author=Coppes MJ, Haber DA, Grundy PE |title=Genetic events in the development of Wilms' tumor |journal=N. Engl. J. Med. |volume=331 |issue=9 |pages=586–90 |year=1994 |month=September |pmid=8047084 |doi=10.1056/NEJM199409013310906 |url=}}</ref>
| |
| *The three phases are also called ''blastemal, epithelial and stromal''.<ref name=Ref_WMSP282>{{Ref WMSP|282}}</ref>
| |
| | |
| Images:
| |
| *[http://www.biologydisease.com/images/kidney/nephrogenic-rests/nephrogenic-rest.jpg.php Nephrogenic rests (biologydisease.com)].
| |
| *[http://www.webpathology.com/image.asp?n=1&Case=73 Wilms tumour (webpathology.com)].
| |
| *[http://commons.wikimedia.org/wiki/File:Wilms_tumour_-_low_mag.jpg Wilms tumour - low mag. (WC)].
| |
| *[http://commons.wikimedia.org/wiki/File:Wilms_tumour_-_very_high_mag.jpg Wilms tumour - very high mag. (WC)].
| |
| | |
| ====Anaplasia====
| |
| Subclassified as:<ref name=Ref_WMSP282>{{Ref WMSP|282}}</ref>
| |
| #Focal anaplasia.
| |
| #Diffuse anaplasia.
| |
| | |
| Criteria (all of the following):<ref name=Ref_WMSP282>{{Ref WMSP|282}}</ref>
| |
| #Atypical mitoses.
| |
| #Nuclear hyperchromasia.
| |
| #Nuclear size variation (of the tumour cells) > 3x.
| |
| | |
| ===IHC===
| |
| *WT-1 +ve.
| |
| | |
| ==Metanephric stromal tumour==
| |
| *Abbreviated ''MST''.
| |
| ===General===
| |
| *Infants and children.
| |
| *Diagnosed as [[mesoblastic nephroma]] in the past.<ref name=Ref_WMSP283>{{Ref WMSP|283}}</ref>
| |
| *Benign and rare.<ref name=pmid11549506>{{Cite journal | last1 = Palese | first1 = MA. | last2 = Ferrer | first2 = F. | last3 = Perlman | first3 = E. | last4 = Gearhart | first4 = JP. | title = Metanephric stromal tumor: a rare benign pediatric renal mass. | journal = Urology | volume = 58 | issue = 3 | pages = 462 | month = Sep | year = 2001 | doi = | PMID = 11549506 }}</ref>
| |
| | |
| ===Gross===
| |
| Features:<ref name=Ref_WMSP283>{{Ref WMSP|283}}</ref>
| |
| *Usu. renal medulla.
| |
| *Solid or cystic.
| |
| | |
| ===Microscopic===
| |
| Features:<ref name=Ref_WMSP283>{{Ref WMSP|283}}</ref>
| |
| *"Collarettes" - tumour cells surround blood vessels ''or'' renal tubules.
| |
| *Spindle cells/stellate cells.
| |
| *Variable cellular density - imparts a nodular appearance at low power.
| |
| *Scant cytoplasm.
| |
| *Induces epithelioid morphology in smooth muscle cells.
| |
| | |
| Notes:
| |
| *+/-Heterologous elements.
| |
| | |
| DDx:
| |
| *Clear cell sarcoma of the kidney.<ref name=pmid11549506/>
| |
| *[[Mesoblastic nephroma]].
| |
| | |
| ==Metanephric adenofibroma==
| |
| ===General===
| |
| *Adults and children.
| |
|
| |
|
| ===Microsopic===
| | Others include: |
| Features:<ref name=Ref_WMSP283>{{Ref WMSP|283}}</ref>
| | *[[Metanephric stromal tumour]]. |
| *Has features of: | | *[[Metanephric adenofibroma]] |
| *#Stromal component.
| | *[[Metanephric adenoma]]. |
| *#*Similar to [[metanephric stromal tumour]]. | | *[[Clear cell sarcoma of the kidney]]. |
| *#Epithelial nodules. | |
| *#*Similar to [[metanephric adenoma]]. | |
|
| |
|
| =See also= | | =See also= |